Unlike the United States, the UK is legalizing cannabidiol, or CBD, because of its medicinal benefits. The US has failed to see the benefits of CBD medicine because of sour political efforts against federal legalization. There has been limited funded research by the FDA, keeping useful studies to a minimum. CBD medicine can help patients with seizures, epilepsy, cancer and a wide range of other illnesses. The legalization of CBD medicine by the UK is one that the United States should follow in order to give the people the best treatment that they have to offer.
Products that contain a cannabis-based ingredient called cannabidiol, or CBD, are to be classed as medicines by the UK medicines regulator from this year.
The Medicines & Healthcare products Regulatory Agency (MHRA) said it had looked at CBD because a number of manufacturing companies had been making “overt medicinal claims” about products.
Gerald Heddel, director of inspection and enforcement at the agency, told Sky News: “The change really came about with us offering an opinion that CBD is in fact a medicine, and that opinion was based on the fact that we noted that people were making some quite stark claims about serious diseases that could be treated with CBD.”
He said that a review of the evidence showed that “it was clear that people are using this product with the understandable belief that it will actually help”.